10x Genomics, Inc. (TXG) stock
TXGNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/30106% above fair value
$54.99−3.20 (-5.50%)
Close on Nov 16, 2026Market cap $7.16BP/E –Yield –
10x Genomics EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for 10x Genomics
10x Genomics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?